Granza Bio

Granza Bio YC 申请

Winter 2024Active

Granza Bio 在 Winter 2024 批次的 Y Combinator 中作为一家 Healthcare 公司进行过。以下是:公司做什么、谁创立了它,以及其 YC 申请,按照真实 YC 表格逐题重建。

YC 批次
Winter 2024
行业
HealthcareTherapeutics
团队规模
7
状态
Active
已发布
2024

创始人

  • Ashwin Nandakumar
    Ashwin NandakumarFounder
  • Ashwin Jainarayanan
    Ashwin JainarayananFounder

Granza Bio 做什么

Granza Bio is developing programmable therapeutics for the immune system. Our platform is built on the foundational discovery of immune “superkiller” attack particles - the natural ammunition used by cytotoxic immune cells to deliver potent, localized killing. By re-arming exhausted immune cells with newly programmed ammunition, Granza restores and enhances immune function. This approach enables a new class of treatments with the potential to transform diseases ranging from cancer to autoimmunity.

Granza Bio 的 YC 申请,重建版

Y Combinator 申请

Granza Bio,Winter 2024 期。来自公开数据的真实申请问题解答。

  1. Founders2
  2. Company7
  3. Progress7
  4. Idea4
  5. Equity3
  6. Curious2
  7. Batch Preference1

Company

Company name

Granza Bio

Describe what your company does in 50 characters or less.

Reprogramming Immunity for Targeted Medicines

What is your company going to make? Please describe your product and what it does or will do.

We develop programmable immune therapeutics based on natural immune "superkiller" attack particles. Our platform re-arms exhausted immune cells with newly programmed ammunition, restoring their ability to attack diseases like cancer and autoimmunity specifically and effectively.

Where do you live now, and where would the company be based after YC?

We live and work in San Francisco, CA, and plan to base the company here after YC.

Explain your decision regarding location.

San Francisco is the biotech and startup hub where we can access talent, partners, and investors necessary to build a new class of immune therapeutics.

21 更多回答 在完整申请中

Founders, Progress, Idea, Equity, Curious, Batch Preference 包含在完整版中。创建免费账户即可在 YC Insights 中打开,紧邻每个其他 YC 批次。

常见问题解答

这是 Granza Bio 的真实 YC 申请吗?

不是。Y Combinator 对提交的申请保密。这是重建版:使用 Granza Bio 的公开数据(发布笔记、创始人背景、产品描述)回答真实的 YC 表格问题。它展示了像 Granza Bio 这样的公司会如何向 YC 自我介绍,而不是他们提交的文本。

Granza Bio 是哪个 YC 批次的?

Granza Bio 是 Y Combinator Winter 2024 批次的成员。

谁创立了 Granza Bio?

Granza Bio 由 Ashwin Nandakumar, Ashwin Jainarayanan 创立。

Granza Bio 做什么?

Reprogramming Immunity for Target-Specific Medicines

如何阅读完整的重建申请?

创建免费的 Round Funded 账户。YC Insights 中包含 Granza Bio 的完整 26 个问题的版本,以及其他所有 YC 批次的公司信息。

更多 YC 初创公司,例如 Granza Bio